Published in Medical Patent Week, October 23rd, 2005
Cobalis currently is conducting clinical trials and recently announced positive preliminary Phase 3 clinical results for PreHistin, the over-the-counter anti-allergy medication the company is developing. Intended to be taken before the onset of allergy season, PreHistin is designed to prevent, rather than just relieve, allergy symptoms. U.S. Patent No. 6,255,294, entitled...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.